Back to search

Peptide record

TPDB05174

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05174
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 SATPdb dbACP iACP-DRLF Antifungipept AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 25-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSVLGSVAQHVLPHVVPVIAEHL
Physicochemical Analysis
C120H198N32O31
RNDCKMFTWY
V
2585.09
6.31
3
1
14
-1
3.63
1.204
171.20
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
1
E
1
Q
2
G
3
H
1
I
5
L
0
K
0
M
0
F
2
P
2
S
0
T
0
W
0
Y
6
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 1 G: 2 H: 3 I: 1 L: 5 K: 0 M: 0 F: 0 P: 2 S: 2 T: 0 W: 0 Y: 0 V: 6
Chemical Descriptors
25
C120H198N32O31
2585.09
6.31
-1
3.63
1.204
Evidence Records 36 records
Evidence 1 Activity

Activity

MIC
Antibacterial
50 µg/mL

Target

B. cereus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 2 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. mult
Evidence 3 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

L. lactis

Source & Reference

dbAMP DRAMP

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. a
Evidence 4 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP DRAMP

Other

vity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. ep
Evidence 5 Activity

Activity

MIC
Antibacterial
1.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP

Other

50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml),
Evidence 6 Activity

Activity

MIC
Antibacterial
25 µg/mL

Target

P. multocida

Source & Reference

dbAMP DRAMP

Other

ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml)
Evidence 7 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1
Evidence 8 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

g/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic
Evidence 9 Activity

Activity

MIC
Antibacterial
100 µg/mL

Target

S. uberis

Source & Reference

dbAMP DRAMP

Other

multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic helices separated by a region o
Evidence 10 Activity

Activity

MIC
Antifungal
50 µg/mL

Target

B. cereus

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 11 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP Antifungipept

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. mult
Evidence 12 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

L. lactis

Source & Reference

dbAMP DRAMP Antifungipept

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. a
Evidence 13 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP DRAMP Antifungipept

Other

vity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. ep
Evidence 14 Activity

Activity

MIC
Antifungal
1.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP DRAMP Antifungipept

Other

50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml),
Evidence 15 Activity

Activity

MIC
Antifungal
25 µg/mL

Target

P. multocida

Source & Reference

dbAMP DRAMP Antifungipept

Other

ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml)
Evidence 16 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP Antifungipept

Other

/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1
Evidence 17 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP Antifungipept

Other

g/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic
Evidence 18 Activity

Activity

MIC
Antifungal
100 µg/mL

Target

S. uberis

Source & Reference

dbAMP DRAMP Antifungipept

Other

multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic helices separated by a region o
Evidence 19 Activity

Activity

MIC
Antiparasitic
50 µg/mL

Target

B. cereus

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 20 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. mult
Evidence 21 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

L. lactis

Source & Reference

dbAMP 3.0 DRAMP

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. a
Evidence 22 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP 3.0 DRAMP

Other

vity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. ep
Evidence 23 Activity

Activity

MIC
Antiparasitic
1.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP

Other

50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml),
Evidence 24 Activity

Activity

MIC
Antiparasitic
25 µg/mL

Target

P. multocida

Source & Reference

dbAMP 3.0 DRAMP

Other

ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml)
Evidence 25 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP

Other

/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1
Evidence 26 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP

Other

g/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic
Evidence 27 Activity

Activity

MIC
Antiparasitic
100 µg/mL

Target

S. uberis

Source & Reference

dbAMP 3.0 DRAMP

Other

multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic helices separated by a region o
Evidence 28 Activity

Activity

MIC
Antiviral
50 µg/mL

Target

B. cereus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus
Evidence 29 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. mult
Evidence 30 Activity

Activity

MIC
Antiviral
25 µg/mL

Target

L. lactis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Activity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. a
Evidence 31 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

L. innocua

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

vity against B. cereus (MIC 50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. ep
Evidence 32 Activity

Activity

MIC
Antiviral
1.5 µg/mL

Target

M. luteus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

50 ug/ml), E. coli (MIC 100 ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml),
Evidence 33 Activity

Activity

MIC
Antiviral
25 µg/mL

Target

P. multocida

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

ug/ml), L. lactis (MIC 25 ug/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml)
Evidence 34 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

/ml), L. innocua (MIC 100 ug/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1
Evidence 35 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

g/ml), M. luteus (MIC 1.5 ug/ml), P. multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic
Evidence 36 Activity

Activity

MIC
Antiviral
100 µg/mL

Target

S. uberis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

multocida (MIC 25 ug/ml), S. aureus (MIC 100 ug/ml), S. epidermidis (MIC 100 ug/ml), and S. uberis (MIC 100 ug/ml). By similarity to Caerin 1.1, it contains two amphipathic helices separated by a region o